1. Home
  2. Analysis
  3. Symbicort
  4. Eucrisa

Symbicort and Eucrisa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Symbicort and Eucrisa. Common interactions include pruritus among females and injection site pain among males.

The phase IV clinical study analyzes what interactions people who take Symbicort and Eucrisa have. It is created by eHealthMe based on reports of 45 people who take Symbicort and Eucrisa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 18, 2023

45 people who take Symbicort and Eucrisa together, and have interactions are studied.

What is Symbicort?

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 99,517 Symbicort users for its effectiveness, alternative drugs and more.

What is Eucrisa?

Eucrisa has active ingredients of crisaborole. eHealthMe is studying from 8,262 Eucrisa users for its effectiveness, alternative drugs and more.

Number of Symbicort and Eucrisa reports submitted per year:

Symbicort and Eucrisa drug interactions.

Common Symbicort and Eucrisa drug interactions by gender *:

female:

  1. Pruritus
  2. Dermatitis atopic
  3. Night blindness
  4. Vision blurred
  5. Weight increased
  6. Cataract
  7. Drug ineffective
  8. Dry skin
  9. Eczema
  10. Administration site pain

male:

  1. Injection site pain
  2. Injection site swelling
  3. Dermatitis atopic
  4. Dysphonia
  5. Eczema
  6. Injection site mass
  7. Keratoconus
  8. Nasopharyngitis
  9. Rash
  10. Surgery

Common Symbicort and Eucrisa drug interactions by age *:

0-1:

n/a

2-9:

  1. Dry skin
  2. Pruritus

10-19:

  1. Angioedema
  2. Dermatitis atopic
  3. Keratoconus
  4. Lip swelling
  5. Periorbital oedema
  6. Skin exfoliation

20-29:

  1. Drug ineffective
  2. Dry skin
  3. Pruritus

30-39:

  1. Dermatitis atopic
  2. Nasopharyngitis
  3. Rash

40-49:

  1. Alopecia
  2. Musculoskeletal stiffness

50-59:

  1. Application site pain
  2. Depressed mood
  3. Dermatitis contact
  4. Disease recurrence
  5. Eczema
  6. Immunosuppression
  7. Lymphadenopathy
  8. Malaise
  9. Neurodermatitis
  10. Oral herpes

60+:

  1. Pruritus
  2. Night blindness
  3. Injection site pain
  4. Limb discomfort
  5. Retinal tear
  6. Surgery
  7. Vitreous floaters
  8. Vision blurred
  9. Weight increased
  10. Cataract

Common conditions people have *:

  1. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 24 people, 53.33%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 8.89%

* Approximation only. Some reports may have incomplete information.

Do you take Symbicort and Eucrisa?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Symbicort and Eucrisa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Symbicort side effects:

Browse all side effects of Symbicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Eucrisa side effects:

Browse all side effects of Eucrisa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Symbicort interactions:

Browse all interactions between Symbicort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Eucrisa interactions:

Browse all interactions between Eucrisa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide; formoterol fumarate dihydrate and crisaborole (the active ingredients of Symbicort and Eucrisa, respectively), and Symbicort and Eucrisa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Symbicort and Eucrisa.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.